Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/25/24 → 6/25/24 |
Financiación
- ModernaTX Incorporated: 10.000,00 US$
A Phase 2, Observer-Blind, Placebo-Controlled, Proof-of-concept Trial to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
- Gedaly, Roberto (PI)
- Rockich, Anna (CoI)